


beyondMD operates as a Houston, TX-based telehealth clinic specializing in peptide therapy, metabolic optimization, and longevity medicine through virtual consultations and at-home treatment programs. The clinic provides access to evidence-based peptide protocols without requiring patients to travel to a physical office, serving individuals throughout Texas who seek functional medicine approaches to weight management, metabolic dysfunction, and age-related decline. beyondMD's model centers on personalized assessment followed by physician-supervised peptide regimens delivered directly to patients' homes, combining clinical oversight with the convenience of remote care.
The clinic's treatment portfolio includes three primary peptide and GLP-1 receptor agonist therapies: PT-141 (bremelanotide) for sexual health and libido enhancement, Semaglutide for weight loss and glycemic control, and Tirzepatide, a dual GIP/GLP-1 receptor agonist offering enhanced metabolic benefits for patients with obesity or type 2 diabetes. beyondMD structures these therapies within comprehensive programs that address underlying metabolic dysfunction rather than isolated symptoms. Semaglutide and Tirzepatide protocols typically involve weekly subcutaneous injections with dosing titrated based on individual response and tolerance, while PT-141 is administered as needed for sexual wellness concerns. The clinic emphasizes that these peptides work through distinct mechanisms—Semaglutide and Tirzepatide modulate appetite and insulin sensitivity through incretin pathways, while PT-141 activates melanocortin receptors involved in sexual arousal—allowing for targeted intervention based on patient goals.
Clinical oversight at beyondMD comes from providers holding board certification in Emergency Medicine and certification by the American Academy of Nurse Practitioners, bringing acute care expertise and advanced practice nursing knowledge to the functional medicine space. This combination of emergency medicine training and nurse practitioner certification provides a foundation for managing potential adverse effects, contraindications, and patient safety concerns that can arise with peptide therapy. The clinic's approach involves initial telehealth consultations to review medical history, current medications, metabolic markers, and treatment objectives, followed by ongoing virtual follow-ups to monitor progress, adjust dosing, and address side effects. Providers evaluate candidacy for each peptide based on factors such as BMI, hemoglobin A1c, cardiovascular risk profile, and concurrent health conditions, ensuring appropriate patient selection for GLP-1 therapies and other peptide interventions.
Patients engaging with beyondMD can expect a fully remote experience beginning with a virtual intake appointment conducted via secure video platform. During this consultation, providers gather comprehensive health information, discuss realistic expectations for peptide therapy, and determine which treatment aligns with the patient's metabolic profile and wellness goals. Once a treatment plan is established, medications are shipped directly to the patient's address with detailed administration instructions, injection supplies, and protocols for storage and handling. The clinic provides ongoing support through follow-up telehealth visits scheduled at regular intervals—typically every four to eight weeks—to assess weight trends, metabolic improvements, tolerance to therapy, and any emerging concerns. This structure allows Houston-area patients and others across Texas to access specialized peptide protocols without the time commitment of in-person appointments, while maintaining clinical accountability through scheduled virtual check-ins.
What distinguishes beyondMD in the Houston telehealth landscape is its focus on at-home program delivery combined with physician oversight of peptide therapies that require careful patient selection and monitoring. Unlike wellness clinics offering broad supplement regimens or general health coaching, beyondMD concentrates specifically on prescription peptide interventions with established mechanisms of action for metabolic and sexual health concerns. The clinic's telehealth-exclusive model eliminates geographic barriers within Texas, making peptide therapy accessible to patients in suburban and rural areas who might otherwise lack local access to providers experienced in these treatments. By combining Emergency Medicine and Nurse Practitioner expertise with a streamlined virtual care model, beyondMD offers a pragmatic option for individuals seeking medically supervised peptide protocols without the overhead of traditional brick-and-mortar functional medicine practices.
John Marley Bernard Jr., MD
Nurse Director
John Bernard, MD graduated from Jefferson Medical College with an MD degree and completed an emergency medicine residency at the State University of New York at Buffalo. He is board certified in Emergency Medicine and has practiced in a variety of emergency departments as well as urgent care and telemedicine settings over the last 20 years.
Hollie Ann Hall, APRN-C
Advanced Practice Registered Nurse
Hollie Ann Hall, APRN-C, graduated from Baker University in 2003 as a registered nurse with a Bachelor of Science in Nursing. Hollie received her degree as a Family Nurse Practitioner from the University of Phoenix in 2010 and is certified by the American Academy of Nurse Practitioners. She enjoys spending time with her family and can be found cheering at her children’s sporting events.
Jordan Dorsey, NP
Nurse Practitioner
Jordan Dorsey, NP, is a compassionate nurse practitioner with expertise in endocrinology, primary care, dermatology, and urology. Jordan specializes in treating erectile and sexual dysfunction, hair loss, libido concerns, and hormone imbalances. Known for creating a supportive environment, Jordan educates and empowers patients to take charge of their health.
Topics Mentioned in Reviews
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


